KMTS Financials

Income Statement
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026
Revenue
31.0M
+8.1%
28.6M
+16.6%
24.6M
+8.8%
22.6M
+16.5%
19.4M
Cost of Revenue
13.5M
+4.0%
13.0M
+11.2%
11.6M
+4.5%
11.1M
+5.9%
10.5M
Gross Profit
17.5M
+11.6%
15.7M
+21.5%
12.9M
+13.0%
11.4M
+29.1%
8.9M
Operating Expenses
55.2M
+0.2%
55.0M
+15.4%
47.7M
+10.4%
43.2M
+14.4%
37.7M
R&D
6.8M
+20.6%
5.6M
+13.3%
5.0M
+1.9%
4.9M
+21.9%
4.0M
SG&A
48.4M
-2.1%
49.4M
+15.7%
42.7M
+11.5%
38.3M
+13.6%
33.7M
Operating Income
-37657000
+4.3%
-39344000
-13.2%
-34765000
-9.5%
-31755000
-10.0%
-28878000
EBITDA
-34993000
+5.5%
-37019000
-12.9%
-32782000
-11.6%
-29382000
-9.4%
-26850000
Net Income
-44087000
-13.5%
-38835000
-13.7%
-34166000
-4.2%
-32785000
-26.9%
-25826000
EPS (Basic)
$-0.75
-11.9%
$-0.67
-9.8%
$-0.61
+4.7%
$-0.64
-28.0%
$-0.50
EPS (Diluted)
$-0.75
-11.9%
$-0.67
-9.8%
$-0.61
+4.7%
$-0.64
-28.0%
$-0.50
Shares (Diluted)
58.6M
+0.6%
58.2M
+4.2%
55.8M
+8.7%
51.4M
+0.1%
51.3M
Kestra Medical Technologies (KMTS) โ€” Financials